Table I.
Log-rank single-factor analysis.
| Clinical factor | Case | χ2 test | P-value |
|---|---|---|---|
| Age, years | 0.785 | 0.940 | |
| 20–29 | 6 | ||
| 30–39 | 20 | ||
| 40–49 | 16 | ||
| 50–59 | 9 | ||
| >59 | 7 | ||
| Tumor side | 0.906 | 0.341 | |
| Right | 35 | ||
| Left | 23 | ||
| Pathological side | 9.070 | 0.011 | |
| Typical testicular seminoma | 29 | ||
| Testicular seminoma combined embryonal carcinoma | 13 | ||
| Testicular seminoma combined embryonal carcinoma as well as teratoma | 16 | ||
| Clinical stage | 7.162 | 0.028 | |
| I | 17 | ||
| II | 32 | ||
| III | 9 | ||
| LDH value | 5.285 | 0.022 | |
| Normal | 24 | ||
| Increasing | 34 | ||
| HCG value | 3.677 | 0.055 | |
| Normal | 32 | ||
| Increasing | 26 | ||
| AFP value | 4.783 | 0.029 | |
| Normal | 31 | ||
| Increasing | 27 | ||
| Postoperative treatment methods | 6.362 | 0.042 | |
| Postoperative radiotherapy | 35 | ||
| Postoperative chemotherapy | 12 | ||
| Postoperative radiotherapy+chemotherapy | 11 |
LDH, lactate dehydrogenase; HCG, human chorionic gonadotropin; AFP, α-fetoprotein.